Table 1.
Preoperative and operative data of HCC cases
| HCC (62 patients) | |
|---|---|
| Viral markers | |
| HCV HBV HCV and HBV |
59 (95.2 %) 2 (3.2 %) 1 (1.6 %) |
| Child score | |
| A B C |
8 (12.9 %) 31 (50 %) 23 (37.1 %) |
| MELD score | |
| Mean ± SD Range MELD <10 MELD 10–20 MELD >20 |
14.2 ± 4.4 (7–34) 6 (9.7 %) 53 (85.5 %) 3 (4.8 %) |
| Ascites | |
| No Mild Moderate Marked |
20 (32.2 %) 13 (21 %) 21 (33.9 %) 8 (12.9 %) |
| AFP (ng/mL) (normal <12 ng/mL) | |
| Mean ± SD Range ≤20 >20, ≤400 >400, <1000 >1000 |
288.3 ± 831.6 (3.4–964) 34 (54.8 %) 20 (32.3 %) 4 (6.45 %) 4 (6.45 %) |
| Milan criteria | |
| Within Beyond |
42 (67.7 %) 20 (32.3 %) |
| UCSF criteria | |
| Within Beyond |
52 (83.9 %) 10 (16.1 %) |
| GRWR | |
| Mean ± SD Range |
1 ± 0.15 (0.7–1.3) |
| CIT (min) | |
| Mean ± SD Range |
61.6 ± 24.1 (25–120) |
| WIT (min) | |
| Mean ± SD Range |
52.5 ± 14.9 (30–95) |
| Oper time (h) | |
| Mean ± SD Range |
14.8 ± 2.4 (8–23) |
| Blood (unit) | |
| Mean ± SD Range |
5.5 ± 6.4 (0–28) |
| Plasma (unit) | |
| Mean ± SD Range |
7.2 ± 10.1 (0–30) |
HCC hepatocellular carcinoma, HCV hepatitis C virus, HBV hepatitis B virus, MELD model of end-stage liver disease, SD standard deviation, AFP alfa-fetoprotein, ng nanogram, mL milli Leter, GRWR graft recipient weight ratio, CIT cold ischemia time, WIT warm ischemia time, UCSF University of California San Francisco criteria